Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 15/04/20111 min de leitura
Determination of Regulatory Review Period for Purposes of Patent Extension; ATRYN; Correction
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of March 21, 2011 (76 FR 15323). The document announced the determination of the regulatory review period for ATRYN. The document was published with an incorrect docket number. This document corrects that error.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →